<\/p>\n
G-Cin is a gemifloxacin tablet (320 mg, Glenmark)<\/strong> \u2014 a fourth-generation respiratory fluoroquinolone with very strong S. pneumoniae and atypical cover. Used for acute exacerbations of chronic bronchitis and mild\u2013moderate community-acquired pneumonia. Higher rash incidence than other fluoroquinolones, particularly in young women.<\/p>\n<\/div>\n \ud83d\udce6 Every order is covered by our Reshipment Assurance Policy<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days, we reship it.<\/p>\n Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging \u2014 no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor \u2014 never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.<\/p>\n G-Cin contains Gemifloxacin<\/strong>, a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV \u2014 the enzymes that supercoil and decatenate bacterial DNA during replication. Without functional gyrase \/ topoisomerase, the bacterial chromosome fragments and the cell dies. Fluoroquinolones are bactericidal and exhibit concentration-dependent killing with a long post-antibiotic effect, supporting once-daily dosing in many indications.<\/p>\n Gemifloxacin is a fourth-generation respiratory fluoroquinolone with very strong Streptococcus pneumoniae activity, atypical pathogen cover, and good Gram-negative activity. It is used primarily for CAP and acute exacerbations of chronic bronchitis. It carries a higher rate of skin rash than other fluoroquinolones, especially in young women.<\/p>\nWhy order from MedsBase<\/h3>\n
How G-Cin works<\/h2>\n
Indications & dosing<\/h2>\n